FDA
-
-
-
-
-
-
-
Pulmonx closes $60 million credit facility with Perceptive Advisors
-
-
-
-
-
-
-
Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025
-
-
-
-
-
-
-
Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
-
-
-
-
-
-
-
Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
-
-
-
-
-
-
-
Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
-
-
-
-
-
-
-
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
-
322,090 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

